These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35872506)

  • 1. The neutrophil-to-lymphocyte ratio is associated with intubation in pediatric anti-NMDA receptor encephalitis: A retrospective study.
    Kashyap N; Morris M; Loerinc LB; Benoit M; Blackwell L; Howarth R; Gombolay G
    J Neuroimmunol; 2022 Sep; 370():577931. PubMed ID: 35872506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of cognitive status in pediatric anti-NMDA receptor encephalitis during inpatient rehabilitation: A retrospective cohort.
    Howarth R; Blackwell L; Gombolay G
    J Neuroimmunol; 2023 Mar; 376():578048. PubMed ID: 36774765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep Characteristics in Pediatric Anti-
    Gombolay G; Morris M; Loerinc L; Blackwell L; Howarth R
    J Child Neurol; 2023 Apr; 38(5):298-306. PubMed ID: 37203168
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammatory markers of hemogram parameters as predictive factors for disease severity in anti-N-methyl-D-aspartate receptor encephalitis.
    Zhang YX; Pu JL; Cai MT; Tao QQ; Tian J; Shen CH; Xu YF; Zhang BR
    Mult Scler Relat Disord; 2022 Nov; 67():104078. PubMed ID: 35985211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of NMDA-receptor subunits NR1, NR2A, and NR2B in dysplastic neurons of teratomas in patients with paraneoplastic NMDA-receptor-encephalitis: a retrospective clinico-pathology study of 159 patients.
    Jiang XY; Lei S; Zhang L; Liu X; Lin MT; Blumcke I; Piao YS; Zhou D; Li JM
    Acta Neuropathol Commun; 2020 Aug; 8(1):130. PubMed ID: 32771066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study.
    Nissen MS; Ørvik MS; Nilsson AC; Ryding M; Lydolph M; Blaabjerg M
    J Neurol; 2022 Mar; 269(3):1618-1630. PubMed ID: 34351472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electroencephalography characteristics to predict one-year outcomes in pediatric anti-NMDA receptor encephalitis.
    Lin J; Elkins K; Bhalla S; Gedela S; Kheder A; Zhang G; Loerinc L; Blackwell L; Howarth R; Gombolay G
    Epilepsy Res; 2021 Dec; 178():106787. PubMed ID: 34715485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel qEEG Biomarker to Distinguish Anti-NMDAR Encephalitis From Other Types of Autoimmune Encephalitis.
    Mizoguchi T; Hara M; Hirose S; Nakajima H
    Front Immunol; 2022; 13():845272. PubMed ID: 35242143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
    Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
    Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Pediatric Cohort Study Validates NEOS Score and Demonstrates Applicability in Children With Anti-NMDAR Encephalitis.
    Nikolaus M; Rausch P; Rostásy K; Bertolini A; Wickström R; Johannsen J; Denecke J; Breu M; Schimmel M; Diepold K; Haeusler M; Quade A; Berger A; Rosewich H; Steen C; von Au K; Dreesmann M; Finke C; Bartels F; Kaindl AM; Schuelke M; Knierim E
    Neurol Neuroimmunol Neuroinflamm; 2023 May; 10(3):. PubMed ID: 36948591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paroxysmal Sympathetic Hyperactivity in Severe Anti-N-Methyl-d-Aspartate Receptor Encephalitis: A Single Center Retrospective Observational Study.
    Wang D; Su S; Tan M; Wu Y; Wang S
    Front Immunol; 2021; 12():665183. PubMed ID: 33912193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic Treatment and Early Rehabilitation Outcomes in Pediatric Patients With Anti-NMDA Receptor Encephalitis.
    Alvarez G; Krentzel A; Vova J; Blackwell L; Howarth R
    Arch Phys Med Rehabil; 2021 Mar; 102(3):406-412. PubMed ID: 33058859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cryptococcal Encephalitis Complicating Anti-N-methyl-D-aspartate Receptor Encephalitis in an Immunosuppressed Patient].
    Liu D; Xu H; Yi F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Jun; 42(3):417-420. PubMed ID: 32616142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological functioning in children and adolescents with anti-NMDA receptor encephalitis (anti-NMDARE).
    Hageboutros K; Hattiangadi Thomas N; Hutchinson M; Banwell B; Baum KT
    J Neurol; 2023 Jan; 270(1):402-412. PubMed ID: 36112199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and electrographic features of persistent seizures and status epilepticus associated with anti-NMDA receptor encephalitis (anti-NMDARE).
    Gofshteyn JS; Yeshokumar AK; Jette N; Thakur KT; Luche N; Yozawitz E; Varnado S; Klenofsky B; Tuohy MC; Ankam J; Torres S; Hesdorffer D; Nelson A; Wolf S; McGoldrick P; Yan H; Basma N; Grinspan Z
    Epileptic Disord; 2020 Dec; 22(6):739-751. PubMed ID: 33258455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influential factors and predictors of anti-N-methyl-D-aspartate receptor encephalitis associated with severity at admission.
    Huang XX; Zhang S; Yan LL; Tang Y; Wu J
    Neurol Sci; 2021 Sep; 42(9):3835-3841. PubMed ID: 33483886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis.
    Guasp M; Martín-Aguilar L; Sabater L; Bioque M; Armangué T; Martínez-Hernández E; Landa J; Maudes E; Borràs R; Muñoz-Lopetegi A; Saiz A; Castro-Fornieles J; Graus F; Parellada E; Querol L; Dalmau J
    Neurology; 2022 Apr; 98(14):e1489-e1498. PubMed ID: 35145006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood and CSF findings of cellular immunity in anti-NMDAR encephalitis.
    Wang J; Luo L; Meng Z; Ren Y; Tang M; Huang Z; Yang B; Niu Q; Zhou D; Wang M; Li J
    Int Immunopharmacol; 2024 Mar; 130():111743. PubMed ID: 38430802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal measurement of cerebrospinal fluid neurofilament light in anti-N-methyl-D-aspartate receptor encephalitis.
    Macher S; Zrzavy T; Höftberger R; Altmann P; Pataraia E; Zimprich F; Berger T; Rommer P
    Eur J Neurol; 2021 Apr; 28(4):1401-1405. PubMed ID: 33145945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity.
    Yu Y; Wu Y; Cao X; Li J; Liao X; Wei J; Huang W
    Mult Scler Relat Disord; 2021 Jan; 47():102604. PubMed ID: 33130468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.